HealthNew Alzheimer’s drug shows efficacy in mid-stage clinical trial, US company says
A US pharmaceutical company says it has confirmed an effect from a new type of Alzheimer’s treatment in a mid-stage clinical trial. The company reported that the drug can slow the progression of symptoms. Development of this type of treatment is accelerating worldwide. The company plans to move on to a final-stage clinical trial aimed at bringing the drug into practical use.
NNHK News★★★☆☆2026-07-15 07:25Original
New Alzheimer’s drug shows efficacy in mid-stage clinical trial, US company says
Health